Literature DB >> 24994937

An EMMPRIN-γ-catenin-Nm23 complex drives ATP production and actomyosin contractility at endothelial junctions.

Vanessa Moreno1, Pilar Gonzalo1, Jesús Gómez-Escudero1, Ángela Pollán1, Rebeca Acín-Pérez1, Mark Breckenridge2, María Yáñez-Mó3, Olga Barreiro1, Fabrizio Orsenigo4, Kenji Kadomatsu5, Christopher S Chen2, José A Enríquez1, Elisabetta Dejana4, Francisco Sánchez-Madrid3, Alicia G Arroyo6.   

Abstract

Cell-cell adhesions are important sites through which cells experience and resist forces. In endothelial cells, these forces regulate junction dynamics and determine endothelial barrier strength. We identify the Ig superfamily member EMMPRIN (also known as basigin) as a coordinator of forces at endothelial junctions. EMMPRIN localization at junctions correlates with endothelial junction strength in different mouse vascular beds. Accordingly, EMMPRIN-deficient mice show altered junctions and increased junction permeability. Lack of EMMPRIN alters the localization and function of VE-cadherin (also known as cadherin-5) by decreasing both actomyosin contractility and tugging forces at endothelial cell junctions. EMMPRIN ensures proper actomyosin-driven maturation of competent endothelial junctions by forming a molecular complex with γ-catenin (also known as junction plakoglobin) and Nm23 (also known as NME1), a nucleoside diphosphate kinase, thereby locally providing ATP to fuel the actomyosin machinery. These results provide a novel mechanism for the regulation of actomyosin contractility at endothelial junctions and might have broader implications in biological contexts such as angiogenesis, collective migration and tissue morphogenesis by coupling compartmentalized energy production to junction assembly.
© 2014. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  ATP; Actomyosin contractility; EMMPRIN; Endothelial junctions; NDPK; Nm23; Nucleoside diphosphate kinase; Vascular integrity; γ-catenin

Mesh:

Substances:

Year:  2014        PMID: 24994937      PMCID: PMC4150062          DOI: 10.1242/jcs.149518

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  52 in total

1.  Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice.

Authors:  Donnasue Graesser; Anna Solowiej; Monika Bruckner; Emily Osterweil; Amy Juedes; Sandra Davis; Nancy H Ruddle; Britta Engelhardt; Joseph A Madri
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

2.  Mechanical tugging force regulates the size of cell-cell junctions.

Authors:  Zhijun Liu; John L Tan; Daniel M Cohen; Michael T Yang; Nathan J Sniadecki; Sami Alom Ruiz; Celeste M Nelson; Christopher S Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-12       Impact factor: 11.205

3.  Junction protein shrew-1 influences cell invasion and interacts with invasion-promoting protein CD147.

Authors:  Alexander Schreiner; Mika Ruonala; Viktor Jakob; Jan Suthaus; Eckhard Boles; Fred Wouters; Anna Starzinski-Powitz
Journal:  Mol Biol Cell       Date:  2007-01-31       Impact factor: 4.138

4.  New insights into the bioenergetics of mitochondrial disorders using intracellular ATP reporters.

Authors:  Carl D Gajewski; Lichuan Yang; Eric A Schon; Giovanni Manfredi
Journal:  Mol Biol Cell       Date:  2003-06-27       Impact factor: 4.138

5.  Effects of flanking genes on the phenotypes of mice deficient in basigin/CD147.

Authors:  Sen Chen; Kenji Kadomatsu; Mineo Kondo; Yoshiro Toyama; Kiyotaka Toshimori; Shinji Ueno; Yozo Miyake; Takashi Muramatsu
Journal:  Biochem Biophys Res Commun       Date:  2004-11-05       Impact factor: 3.575

6.  Vinculin associates with endothelial VE-cadherin junctions to control force-dependent remodeling.

Authors:  Stephan Huveneers; Joppe Oldenburg; Emma Spanjaard; Gerard van der Krogt; Ilya Grigoriev; Anna Akhmanova; Holger Rehmann; Johan de Rooij
Journal:  J Cell Biol       Date:  2012-03-05       Impact factor: 10.539

7.  Regulation of endothelial cell motility by complexes of tetraspan molecules CD81/TAPA-1 and CD151/PETA-3 with alpha3 beta1 integrin localized at endothelial lateral junctions.

Authors:  M Yáñez-Mó; A Alfranca; C Cabañas; M Marazuela; R Tejedor; M A Ursa; L K Ashman; M O de Landázuri; F Sánchez-Madrid
Journal:  J Cell Biol       Date:  1998-05-04       Impact factor: 10.539

8.  Rap1 potentiates endothelial cell junctions by spatially controlling myosin II activity and actin organization.

Authors:  Koji Ando; Shigetomo Fukuhara; Takahiro Moriya; Yutaro Obara; Norimichi Nakahata; Naoki Mochizuki
Journal:  J Cell Biol       Date:  2013-09-09       Impact factor: 10.539

9.  A genetically encoded fluorescent reporter of ATP:ADP ratio.

Authors:  Jim Berg; Yin Pun Hung; Gary Yellen
Journal:  Nat Methods       Date:  2009-01-04       Impact factor: 28.547

10.  Actomyosin interaction: mechanical and energetic properties in different nucleotide binding states.

Authors:  Iuliana Aprodu; Alberto Redaelli; Monica Soncini
Journal:  Int J Mol Sci       Date:  2008-10-13       Impact factor: 6.208

View more
  16 in total

1.  The NDPK/NME superfamily: state of the art.

Authors:  Mathieu Boissan; Uwe Schlattner; Marie-Lise Lacombe
Journal:  Lab Invest       Date:  2018-02       Impact factor: 5.662

2.  ROCK2 primes the endothelium for vascular hyperpermeability responses by raising baseline junctional tension.

Authors:  Cora M L Beckers; Nebojsa Knezevic; Erik T Valent; Mohammad Tauseef; Ramaswamy Krishnan; Kavitha Rajendran; C Corey Hardin; Jurjan Aman; Jan van Bezu; Paul Sweetnam; Victor W M van Hinsbergh; Dolly Mehta; Geerten P van Nieuw Amerongen
Journal:  Vascul Pharmacol       Date:  2015-04-11       Impact factor: 5.773

3.  Hypoxia tolerance in the Norrin-deficient retina and the chronically hypoxic brain studied at single-cell resolution.

Authors:  Jacob S Heng; Amir Rattner; Genevieve L Stein-O'Brien; Briana L Winer; Bryan W Jones; Hilary J Vernon; Loyal A Goff; Jeremy Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-15       Impact factor: 11.205

Review 4.  Basigin (CD147), a multifunctional transmembrane glycoprotein with various binding partners.

Authors:  Takashi Muramatsu
Journal:  J Biochem       Date:  2015-12-18       Impact factor: 3.387

5.  Curcumin modulates chronic myelogenous leukemia exosomes composition and affects angiogenic phenotype via exosomal miR-21.

Authors:  Simona Taverna; Simona Fontana; Francesca Monteleone; Marzia Pucci; Laura Saieva; Viviana De Caro; Valeria Giunta Cardinale; Marco Giallombardo; Emanuela Vicario; Christian Rolfo; Giacomo De Leo; Riccardo Alessandro
Journal:  Oncotarget       Date:  2016-05-24

6.  Self-propelling vesicles define glycolysis as the minimal energy machinery for neuronal transport.

Authors:  María-Victoria Hinckelmann; Amandine Virlogeux; Christian Niehage; Christel Poujol; Daniel Choquet; Bernard Hoflack; Diana Zala; Frédéric Saudou
Journal:  Nat Commun       Date:  2016-10-24       Impact factor: 14.919

7.  Glycolytic regulation of cell rearrangement in angiogenesis.

Authors:  Bert Cruys; Brian W Wong; Anna Kuchnio; Dries Verdegem; Anna Rita Cantelmo; Lena-Christin Conradi; Saar Vandekeere; Ann Bouché; Ivo Cornelissen; Stefan Vinckier; Roeland M H Merks; Elisabetta Dejana; Holger Gerhardt; Mieke Dewerchin; Katie Bentley; Peter Carmeliet
Journal:  Nat Commun       Date:  2016-07-20       Impact factor: 14.919

Review 8.  Beyond cell-cell adhesion: Plakoglobin and the regulation of tumorigenesis and metastasis.

Authors:  Zackie Aktary; Mahsa Alaee; Manijeh Pasdar
Journal:  Oncotarget       Date:  2017-05-09

9.  The relationship of NM23 (NME) metastasis suppressor histidine phosphorylation to its nucleoside diphosphate kinase, histidine protein kinase and motility suppression activities.

Authors:  Imran Khan; Patricia S Steeg
Journal:  Oncotarget       Date:  2017-12-31

Review 10.  Cell-cell junctional mechanotransduction in endothelial remodeling.

Authors:  Yvonne L Dorland; Stephan Huveneers
Journal:  Cell Mol Life Sci       Date:  2016-08-09       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.